Willdan Group (WLDN) Earnings Analysis
Willdan Group (WLDN) has no confirmed upcoming earnings date. Last quarter (2026-05-07) it beat with EPS 0.91 USD vs 0.81 USD est (+12.3%). It has beaten estimates in 6/6 recent quarters (100%). Trailing P/E 19.26.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does WLDN next report earnings?
No confirmed upcoming earnings date is currently scheduled for WLDN. This page updates as the calendar is published.
WLDN earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-07 | 0.91 USD | 0.81 USD | +12.3% | Beat |
| 2026-02-26 | 1.57 USD | 0.79 USD | +98.7% | Beat |
| 2025-11-06 | 1.21 USD | 0.81 USD | +49.4% | Beat |
| 2025-03-06 | 0.75 USD | 0.57 USD | +31.6% | Beat |
| 2024-10-31 | 0.73 USD | 0.55 USD | +32.7% | Beat |
| 2024-08-01 | 0.55 USD | 0.29 USD | +89.7% | Beat |
Beat rate: 6/6 (100%) over reported quarters with consensus data.
WLDN valuation and analyst view
| Trailing P/E | 19.26 |
|---|---|
| Trailing EPS | 3.826 USD |
| Price / book | 3.54 |
| Dividend yield | 0.00% |
| Market cap | 1.13B |
| Analyst consensus | Buy (7 buy / 0 hold / 0 sell) |
| Avg price target | 120.75 USD |
Related research pages
Frequently asked questions
When is Willdan Group (WLDN)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for WLDN. This page updates as the calendar is published.
Did WLDN beat earnings last quarter?
In its 2026-05-07 report, WLDN posted EPS of 0.91 USD versus a 0.81 USD estimate — a beat of 12.3%.
What is WLDN's earnings track record?
Over the last 6 reported quarters with consensus data, WLDN beat estimates 6 times (100%).
What is WLDN's current P/E ratio and EPS?
WLDN trades at a trailing P/E of 19.26 on trailing EPS of 3.8263229308005426 USD.
What do analysts rate WLDN?
Analyst consensus is "Buy" across 7 ratings (0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 120.75 USD.